Lymphocyte-Rich Classical Hodgkin Lymphoma:

DOI PubMed 参考文献14件 オープンアクセス
  • Sakai Jun
    Department of Hematology, International Medical Center, Saitama Medical University
  • Tanae Ken
    Department of Hematology, Iwate Central Hospital
  • Takahashi Naoki
    Department of Hematology, International Medical Center, Saitama Medical University
  • Nagata Koji
    Department of Pathology, International Medical Center, Saitama Medical University
  • Yoshino Tadashi
    Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
  • Tamaru Jun-ichi
    Department of Pathology, Medical Center, Saitama Medical University
  • Niitsu Nozomi
    Department of Hematology, International Medical Center, Saitama Medical University

書誌事項

タイトル別名
  • A Case with Difficulty in Distinguishing from Nodular Lymphocyte-Predominant Hodgkin Lymphoma

この論文をさがす

説明

A 35-year-old man was referred to our hospital because of left supraclavicular and cervical lymphadenopathies. Histopathological examination of the lymph nodes revealed reactive lymphadenopathy. He visited our hospital three years after the initial diagnosis because of enlarged left cervical lymph nodes. Histopathologically, both Hodgkin/Reed-Sternberg (H/RS) and lymphocyte-predominant (LP) cells were found in the lymph node. We first suspected nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL), because these cells were CD15- and CD30-. However, the diagnosis of lymphocyte-rich classical Hodgkin lymphoma (LRCHL) was finally confirmed, because these cells were found to be CD20-, Bob.1+, Oct.2-, and BCL6- by additional immunostaining. The patient was treated with six cycles of ABVD chemotherapy, and a complete response was achieved. However, he underwent autologous stem-cell transplantation after high-dose chemotherapy owing to a relapse 10 months after primary treatment. Distingushing LRCHL from NLPHL was difficult in this patient, because histopathological examination showed both H/RS and LP cells, and immunostaining revealed these cells to be triple negative (CD15-, CD30- and CD20-). Accumulation of such cases are necessary to establish better criteria for the differential diagnosis and assessment of clinical behavior.

収録刊行物

参考文献 (14)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ